FDA Commissioner Marty Makary defends Replimune drug approval decisionBy FinMar NewsMay 5, 2026Martin Makary, commissioner of the Food and Drug Administration (FDA), during a news conference at the US Food and Drug Administration headquarters in Silver Spring, Maryland,…
